Evidence map›Paper›PMID 27041589›Full record

ArticleScientific reports2016

Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular Performance.

Esther Roselló-Lletí, Ricardo Carnicer, Estefanía Tarazón, Ana Ortega, Carolina Gil-Cayuela, Francisca Lago, Jose Ramón González-Juanatey, Manuel Portolés, Miguel Rivera

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Esther Roselló-LletíCardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain.
Ricardo CarnicerDepartment of Cardiovascular Medicine, University of Oxford, United Kingdom.
Estefanía TarazónCardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain.
Ana OrtegaCardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain.
Carolina Gil-CayuelaCardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain.
Francisca LagoCellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.
Jose Ramón González-JuanateyCellular and Molecular Cardiology Research Unit, Department of Cardiology and Institute of Biomedical Research, University Clinical Hospital, Santiago de Compostela, Spain.
Manuel PortolésCardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain.
Miguel RiveraCardiocirculatory Unit, Health Institute of La Fe University Hospital (IIS La Fe), Valencia, Spain.
Instituto de Investigación Sanitaria La Fe · ESUniversity of Oxford · GB

Funding

British Heart Foundation FS/15/15/31364
6 · The paper itself

Abstract

The role of nitric oxide synthase 1 (NOS1) as a major modulator of cardiac function has been extensively studied in experimental models; however, its role in human ischemic cardiomyopathy (ICM) has never been analysed. Thus, the objectives of this work are to study NOS1 and NOS-related counterparts involved in regulating physiological function of myocyte, to analyze NOS1 localisation, activity, dimerisation, and its relationship with systolic function in ICM. The study has been carried out on left ventricular tissue obtained from explanted human hearts. Here we demonstrate that the upregulation of cardiac NOS1 is not accompanied by an increase in NOS activity, due in part to the alterations found in molecules involved in the regulation of its activity. We observed partial translocation of NOS1 to the sarcolemma in ischemic hearts, and a direct relationship between its protein levels and systolic ventricular function. Our findings indicate that NOS1 may be significant in the pathophysiology of human ischemic heart disease with a preservative role in maintaining myocardial homeostasis.

Indexed as

Up-RegulationVentricular Function, LeftGene Expression RegulationHumansMaleMiddle AgedMyocardial IschemiaNitric Oxide Synthase Type IProtein TransportSarcolemmaSequence Analysis, RNANitric Oxide Synthase Type INOS1 protein, human

Identifiers

PMID27041589
PMCPMC4819187
OpenAlexW2338583422

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.